Use of ECMO in Acute MI

Use of Extracorporeal Membrane Oxygenation in Treatment of Acute Myocardial Infarction Following Cardiac Surgery Procedures

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00425685

Enrollment

Registered

2007-01-23

Start date

2003-01-31

Completion date

2006-12-31

Last updated

2007-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ECMO and Acute MI

Keywords

cardiopulmonary resuscitation, ECMO, shock, survival, heart failure, transplantation, heart assist device.

Brief summary

ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Improvement in intermediate term outcome will require multidisciplinary approach to protect organ function and limit organ injury during this support.

Detailed description

Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.

Interventions

None listed

Study design

Observational model

DEFINED_POPULATION

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

17 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Acute MI

Exclusion criteria

* Contraindication against ECMO

Outcome results